Ping Shek

Ping Shek

Managing Director

London Office  |   |   +44 (0) 207 451 4552

Ping Shek, a Managing Director in Torreya’s London office, works on strategic transactions and financings for European companies.

Ping has expertise in cross-border transactions, having worked on deals in more than 25 jurisdictions throughout North America, Europe, Middle East, South Asia, East Asia, Australasia, and Africa.

Before joining Torreya in 2017, Ping helped develop the M&A advisory business at PharmaVentures, where he worked on transactions and strategy assignments in biotech, pharma, pharma services, medical devices, life science tools, and healthcare services worldwide.

Ping was a co-founder of the integrated strategy/M&A execution practice at Monitor Group and played a pivotal role in growing the practice in London, New York and Boston. Earlier, Ping served as an Associate at Lazard in London, where he worked on public takeovers, M&A transactions, IPOs, rights issues, privatizations, and restructurings. Ping began his investment banking career as an Analyst in the M&A Department at Morgan Stanley’s London office.

Ping holds an M.A. in physics from Oxford University, as well as an M.B.A. with distinction in advanced corporate finance from London Business School.

Selected Transactions

Divestment of Leiden, Netherlands facility to
December 2022
Sale of U.S. manufacturing facility and long-term supply agreement with
$44.5 million
April 2022
Sirion Biotech
Acquired by
Up to $180 million
September 2021
Management buyout of
Skyepharma SAS
June 2021
FairJourney Biologics
Investment by
GHO Capital Partners
January 2020
BE Vaccines SAS sale to Clean Cells, a portfolio company of
March 2019